
Astellas Pharma and 4D Molecular Therapeutics (4DMT) have announced a license agreement under which Astellas has the right to use …

SIRION Biotech and Sanofi have entered into an agreement to develop effective medicines for illnesses impacting major human organs.
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion

